NASDAQ:PMTI - Palomar Medical Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$13.41 0.00 (0.00 %)
(As of 05/23/2018 04:00 PM ET)
Previous Close$13.41
Today's RangeN/A
52-Week Range$7.06 - $13.97
Average Volume128,366 shs
Market Capitalization$267.90 million
P/E RatioN/A
Dividend YieldN/A

About Palomar Medical Technologies (NASDAQ:PMTI)

Palomar Medical Technologies logoPalomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.

Receive PMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for PMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Palomar Medical Technologies (NASDAQ:PMTI) Frequently Asked Questions

What is Palomar Medical Technologies' stock symbol?

Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."

Who are Palomar Medical Technologies' key executives?

Palomar Medical Technologies' management team includes the folowing people:
  • Joseph P. Caruso, Chairman of the Board, President, Chief Executive Officer (Age 54)
  • Paul S. Weiner, Chief Financial Officer, Treasurer (Age 53)
  • Louis P. Valente, Director (Age 81)
  • Jeanne Cohane, Independent Director (Age 65)
  • Damian N. Dell'Anno, Independent Director
  • Nicholas P. Economou Ph.D., Independent Director (Age 63)
  • James G. Martin Ph.D., Independent Director (Age 78)

Has Palomar Medical Technologies been receiving favorable news coverage?

News stories about PMTI stock have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Palomar Medical Technologies earned a news sentiment score of 0.21 on Accern's scale. They also assigned news articles about the healthcare company an impact score of 44.52 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Palomar Medical Technologies?

Shares of PMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palomar Medical Technologies' stock price today?

One share of PMTI stock can currently be purchased for approximately $13.41.

How big of a company is Palomar Medical Technologies?

Palomar Medical Technologies has a market capitalization of $267.90 million.

How can I contact Palomar Medical Technologies?

Palomar Medical Technologies' mailing address is 15 Network Drive, BURLINGTON, MA 1803, United States. The healthcare company can be reached via phone at +1-781-9932300.

MarketBeat Community Rating for Palomar Medical Technologies (PMTI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe PMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Palomar Medical Technologies (NASDAQ:PMTI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/23/2016 forward)


Palomar Medical Technologies (NASDAQ:PMTI) Earnings History and Estimates Chart

Earnings by Quarter for Palomar Medical Technologies (NASDAQ:PMTI)

Palomar Medical Technologies (NASDAQ PMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2013Q1 2013($0.01)($0.06)$20.30 million$23.20 millionViewN/AView Earnings Details
2/7/2013Q4 2012$0.04$0.12$22.70 million$23.40 millionViewN/AView Earnings Details
10/25/2012($0.09)($0.25)ViewN/AView Earnings Details
7/26/2012($0.10)($0.08)ViewN/AView Earnings Details
4/26/2012($0.05)($0.12)ViewN/AView Earnings Details
2/9/2012($0.11)($0.10)ViewN/AView Earnings Details
10/27/2011($0.14)$0.81ViewN/AView Earnings Details
7/28/2011($0.12)($0.21)ViewN/AView Earnings Details
4/28/2011($0.10)($0.10)ViewN/AView Earnings Details
2/10/2011($0.09)($0.14)ViewN/AView Earnings Details
10/28/2010Q3 2010($0.11)($0.06)ViewN/AView Earnings Details
7/29/2010Q2 2010($0.10)($0.09)ViewN/AView Earnings Details
4/29/2010Q1 2010($0.10)($0.14)ViewN/AView Earnings Details
2/11/2010Q4 2009($0.01)($0.17)ViewN/AView Earnings Details
10/29/2009Q3 2009($0.01)($0.01)ViewN/AView Earnings Details
7/30/2009Q2 2009($0.04)($0.01)ViewN/AView Earnings Details
4/30/2009Q1 2009($0.03)($0.08)ViewN/AView Earnings Details
2/5/2009Q4 2008$0.07($0.02)ViewN/AView Earnings Details
10/30/2008Q3 2008$0.09$0.11ViewN/AView Earnings Details
7/31/2008Q2 2008$0.07$0.04ViewN/AView Earnings Details
5/1/2008Q1 2008$0.11$0.09ViewN/AView Earnings Details
2/7/2008Q4 2007$0.28$0.22ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Palomar Medical Technologies (NASDAQ:PMTI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Palomar Medical Technologies (NASDAQ PMTI) Insider Trading and Institutional Ownership History

Insider Trading History for Palomar Medical Technologies (NASDAQ:PMTI)

Palomar Medical Technologies (NASDAQ PMTI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/12/2013A Neil PappalardoDirectorSell15,000$13.45$201,750.00View SEC Filing  
6/11/2013Joseph P CarusoCEOSell21,711$13.42$291,361.62View SEC Filing  
6/7/2013Joseph P CarusoCEOSell2,056$13.47$27,694.32View SEC Filing  
5/28/2013Joseph P CarusoCEOSell40,000$13.60$544,000.00View SEC Filing  
5/24/2013Joseph P CarusoCEOSell19,028$13.58$258,400.24View SEC Filing  
5/24/2013Paul S WeinerCFOSell78,338$13.59$1,064,613.42View SEC Filing  
5/22/2013Joseph P CarusoCEOSell20,000$13.58$271,600.00View SEC Filing  
5/17/2013Joseph P CarusoCEOSell22,900$13.58$310,982.00View SEC Filing  
5/15/2013Joseph P CarusoCEOSell70,000$13.58$950,600.00View SEC Filing  
5/14/2013Paul S WeinerCFOSell40,485$13.60$550,596.00View SEC Filing  
5/9/2013James G MartinDirectorSell14,756$13.52$199,501.12View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy13,118$7.19$94,318.42View SEC Filing  
(Data available from 1/1/2013 forward)


Palomar Medical Technologies (NASDAQ PMTI) News Headlines

Head to Head Review: Sientra (SIEN) & Palomar Medical Technologies (PMTI)Head to Head Review: Sientra (SIEN) & Palomar Medical Technologies (PMTI) - March 14 at 3:10 AM
Critical Comparison: DexCom (DXCM) and Palomar Medical Technologies (PMTI)Critical Comparison: DexCom (DXCM) and Palomar Medical Technologies (PMTI) - March 11 at 1:23 AM
Financial Comparison: Bio-Rad Laboratories (BIO) vs. Palomar Medical Technologies (PMTI)Financial Comparison: Bio-Rad Laboratories (BIO) vs. Palomar Medical Technologies (PMTI) - March 4 at 5:10 AM
Comparing Halyard Health (HYH) and Palomar Medical Technologies (PMTI)Comparing Halyard Health (HYH) and Palomar Medical Technologies (PMTI) - December 31 at 3:28 AM
Contrasting Palomar Medical Technologies (PMTI) and Its RivalsContrasting Palomar Medical Technologies (PMTI) and Its Rivals - December 14 at 9:52 AM
Palomar Medical Technologies (PMTI) and Its Rivals Financial SurveyPalomar Medical Technologies (PMTI) and Its Rivals Financial Survey - December 11 at 11:26 AM
Contrasting Palomar Medical Technologies (PMTI) & Its RivalsContrasting Palomar Medical Technologies (PMTI) & Its Rivals - December 6 at 5:36 AM
Contrasting Palomar Medical Technologies (PMTI) & The CompetitionContrasting Palomar Medical Technologies (PMTI) & The Competition - November 30 at 1:50 PM
Comparing Palomar Medical Technologies (PMTI) & Its PeersComparing Palomar Medical Technologies (PMTI) & Its Peers - November 16 at 8:36 AM

SEC Filings

Palomar Medical Technologies (NASDAQ:PMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Palomar Medical Technologies (NASDAQ:PMTI) Income Statement, Balance Sheet and Cash Flow Statement


Palomar Medical Technologies (NASDAQ PMTI) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.